eBook
View in EDS

Advances in the Treatment of Kidney and Upper Urinary Tract Cancers

Bibliographic Details
Title: Advances in the Treatment of Kidney and Upper Urinary Tract Cancers
Contributors: Zapała, Łukasz, Rajwa, Pawel
Publisher Information: MDPI - Multidisciplinary Digital Publishing Institute, 2024.
Publication Year: 2024
Subject Terms: renal cell carcinoma, risk models, survival analysis, charlson comorbidity index, systemic inflammatory markers, upper tract urothelial carcinoma, UTUC, sPD-L1, soluble programmed death ligand-1, biomarker, prognosis, immune checkpoint inhibitor therapy, chemotherapy, radical nephroureterectomy, focal therapy, kidney cancer, thermal ablation, renal carcinoma, RCC, PD-1, PD-L1, nivolumab, kidney tumor, systemic inflammatory response syndrome, nephrectomy, globotriaosylceramide, rhamnose-binding lectin, sunitinib, brain metastases, neurosurgery, targeted therapy, basement membrane, diagnostic, renal cancer, lncRNA, prognostic model, immunotherapy, prostate cancer, transplant, immunosuppression, progression, metastatic prostate cancer, upper tract urothelial cancer, Balkan endemic nephropathy, morphology, CKs, CD44, tyrosine kinase inhibitors (TKI), cabozantinib, metastatic renal cell carcinoma (mRCC), adverse events, predictive factor, Applied mathematics
More Details: Kidney and Upper Tract Urinary Cancers (UTUCs) are diseases of increasing population coverage, the treatment of which is undergoing a continuous process of evolution. A characteristic feature of renal cell cancer (RCC) treatment is the significant heterogeneity of patients (including different stages of local advancement and different locations of metastases). Importantly, it is estimated that up to 30% of newly diagnosed RCC cases are patients with disseminated disease at the time of diagnosis. Therefore, predicting the response to modern treatment remains the unmet need of modern urologic oncology. Recent advancements in systematic treatment, i.e., immunotherapy, shed additional light on adjuvant treatment to be implemented in new clinical scenarios, including localized disease.
Document Type: eBook
File Description: application/octet-stream
Language: English
ISBN: 978-3-7258-0553-2
978-3-7258-0554-9
DOI: 10.3390/books978-3-7258-0554-9
Access URL: https://directory.doabooks.org/handle/20.500.12854/137710
https://mdpi.com/books/pdfview/book/8935
Rights: Attribution-NonCommercial-NoDerivatives 4.0 International
open access
URL: http://purl.org/coar/access_right/c_abf2
URL: https://creativecommons.org/licenses/by-nc-nd/4.0/
Notes: ONIX_20240514_9783725805532_307
Accession Number: edsdob.20.500.12854.137710
Database: Directory of Open Access Books
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdob&genre=book&issn=&ISBN=9783725805532&volume=&issue=&date=&spage=&pages=&title=Advances in the Treatment of Kidney and Upper Urinary Tract Cancers&atitle=Advances%20in%20the%20Treatment%20of%20Kidney%20and%20Upper%20Urinary%20Tract%20Cancers&aulast=Zapa%C5%82a%2C%20%C5%81ukasz&id=DOI:10.3390/books978-3-7258-0554-9
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: edsdob
DbLabel: Directory of Open Access Books
An: edsdob.20.500.12854.137710
RelevancyScore: 1029
AccessLevel: 3
PubType: eBook
PubTypeId: ebook
PreciseRelevancyScore: 1029.35363769531
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Advances in the Treatment of Kidney and Upper Urinary Tract Cancers
– Name: Author
  Label: Contributors
  Group: Au
  Data: Zapała, Łukasz<br />Rajwa, Pawel
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: MDPI - Multidisciplinary Digital Publishing Institute, 2024.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2024
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22renal+cell+carcinoma%22">renal cell carcinoma</searchLink><br /><searchLink fieldCode="DE" term="%22risk+models%22">risk models</searchLink><br /><searchLink fieldCode="DE" term="%22survival+analysis%22">survival analysis</searchLink><br /><searchLink fieldCode="DE" term="%22charlson+comorbidity+index%22">charlson comorbidity index</searchLink><br /><searchLink fieldCode="DE" term="%22systemic+inflammatory+markers%22">systemic inflammatory markers</searchLink><br /><searchLink fieldCode="DE" term="%22upper+tract+urothelial+carcinoma%22">upper tract urothelial carcinoma</searchLink><br /><searchLink fieldCode="DE" term="%22UTUC%22">UTUC</searchLink><br /><searchLink fieldCode="DE" term="%22sPD-L1%22">sPD-L1</searchLink><br /><searchLink fieldCode="DE" term="%22soluble+programmed+death+ligand-1%22">soluble programmed death ligand-1</searchLink><br /><searchLink fieldCode="DE" term="%22biomarker%22">biomarker</searchLink><br /><searchLink fieldCode="DE" term="%22prognosis%22">prognosis</searchLink><br /><searchLink fieldCode="DE" term="%22immune+checkpoint+inhibitor+therapy%22">immune checkpoint inhibitor therapy</searchLink><br /><searchLink fieldCode="DE" term="%22chemotherapy%22">chemotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22radical+nephroureterectomy%22">radical nephroureterectomy</searchLink><br /><searchLink fieldCode="DE" term="%22focal+therapy%22">focal therapy</searchLink><br /><searchLink fieldCode="DE" term="%22kidney+cancer%22">kidney cancer</searchLink><br /><searchLink fieldCode="DE" term="%22thermal+ablation%22">thermal ablation</searchLink><br /><searchLink fieldCode="DE" term="%22renal+carcinoma%22">renal carcinoma</searchLink><br /><searchLink fieldCode="DE" term="%22RCC%22">RCC</searchLink><br /><searchLink fieldCode="DE" term="%22PD-1%22">PD-1</searchLink><br /><searchLink fieldCode="DE" term="%22PD-L1%22">PD-L1</searchLink><br /><searchLink fieldCode="DE" term="%22nivolumab%22">nivolumab</searchLink><br /><searchLink fieldCode="DE" term="%22kidney+tumor%22">kidney tumor</searchLink><br /><searchLink fieldCode="DE" term="%22systemic+inflammatory+response+syndrome%22">systemic inflammatory response syndrome</searchLink><br /><searchLink fieldCode="DE" term="%22nephrectomy%22">nephrectomy</searchLink><br /><searchLink fieldCode="DE" term="%22globotriaosylceramide%22">globotriaosylceramide</searchLink><br /><searchLink fieldCode="DE" term="%22rhamnose-binding+lectin%22">rhamnose-binding lectin</searchLink><br /><searchLink fieldCode="DE" term="%22sunitinib%22">sunitinib</searchLink><br /><searchLink fieldCode="DE" term="%22brain+metastases%22">brain metastases</searchLink><br /><searchLink fieldCode="DE" term="%22neurosurgery%22">neurosurgery</searchLink><br /><searchLink fieldCode="DE" term="%22targeted+therapy%22">targeted therapy</searchLink><br /><searchLink fieldCode="DE" term="%22basement+membrane%22">basement membrane</searchLink><br /><searchLink fieldCode="DE" term="%22diagnostic%22">diagnostic</searchLink><br /><searchLink fieldCode="DE" term="%22renal+cancer%22">renal cancer</searchLink><br /><searchLink fieldCode="DE" term="%22lncRNA%22">lncRNA</searchLink><br /><searchLink fieldCode="DE" term="%22prognostic+model%22">prognostic model</searchLink><br /><searchLink fieldCode="DE" term="%22immunotherapy%22">immunotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22prostate+cancer%22">prostate cancer</searchLink><br /><searchLink fieldCode="DE" term="%22transplant%22">transplant</searchLink><br /><searchLink fieldCode="DE" term="%22immunosuppression%22">immunosuppression</searchLink><br /><searchLink fieldCode="DE" term="%22progression%22">progression</searchLink><br /><searchLink fieldCode="DE" term="%22metastatic+prostate+cancer%22">metastatic prostate cancer</searchLink><br /><searchLink fieldCode="DE" term="%22upper+tract+urothelial+cancer%22">upper tract urothelial cancer</searchLink><br /><searchLink fieldCode="DE" term="%22Balkan+endemic+nephropathy%22">Balkan endemic nephropathy</searchLink><br /><searchLink fieldCode="DE" term="%22morphology%22">morphology</searchLink><br /><searchLink fieldCode="DE" term="%22CKs%22">CKs</searchLink><br /><searchLink fieldCode="DE" term="%22CD44%22">CD44</searchLink><br /><searchLink fieldCode="DE" term="%22tyrosine+kinase+inhibitors+%28TKI%29%22">tyrosine kinase inhibitors (TKI)</searchLink><br /><searchLink fieldCode="DE" term="%22cabozantinib%22">cabozantinib</searchLink><br /><searchLink fieldCode="DE" term="%22metastatic+renal+cell+carcinoma+%28mRCC%29%22">metastatic renal cell carcinoma (mRCC)</searchLink><br /><searchLink fieldCode="DE" term="%22adverse+events%22">adverse events</searchLink><br /><searchLink fieldCode="DE" term="%22predictive+factor%22">predictive factor</searchLink><br /><searchLink fieldCode="DE" term="%22Applied+mathematics%22">Applied mathematics</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Kidney and Upper Tract Urinary Cancers (UTUCs) are diseases of increasing population coverage, the treatment of which is undergoing a continuous process of evolution. A characteristic feature of renal cell cancer (RCC) treatment is the significant heterogeneity of patients (including different stages of local advancement and different locations of metastases). Importantly, it is estimated that up to 30% of newly diagnosed RCC cases are patients with disseminated disease at the time of diagnosis. Therefore, predicting the response to modern treatment remains the unmet need of modern urologic oncology. Recent advancements in systematic treatment, i.e., immunotherapy, shed additional light on adjuvant treatment to be implemented in new clinical scenarios, including localized disease.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: eBook
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: application/octet-stream
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISBN
  Label: ISBN
  Group: ISBN
  Data: 978-3-7258-0553-2<br />978-3-7258-0554-9
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.3390/books978-3-7258-0554-9
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://directory.doabooks.org/handle/20.500.12854/137710" linkWindow="_blank">https://directory.doabooks.org/handle/20.500.12854/137710</link><br /><link linkTarget="URL" linkTerm="https://mdpi.com/books/pdfview/book/8935" linkWindow="_blank">https://mdpi.com/books/pdfview/book/8935</link>
– Name: Copyright
  Label: Rights
  Group: Cpyrght
  Data: Attribution-NonCommercial-NoDerivatives 4.0 International<br />open access<br />URL: http://purl.org/coar/access_right/c_abf2<br />URL: https://creativecommons.org/licenses/by-nc-nd/4.0/
– Name: Note
  Label: Notes
  Group:
  Data: ONIX_20240514_9783725805532_307
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdob.20.500.12854.137710
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdob&AN=edsdob.20.500.12854.137710
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/books978-3-7258-0554-9
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 174
    Subjects:
      – SubjectFull: renal cell carcinoma
        Type: general
      – SubjectFull: risk models
        Type: general
      – SubjectFull: survival analysis
        Type: general
      – SubjectFull: charlson comorbidity index
        Type: general
      – SubjectFull: systemic inflammatory markers
        Type: general
      – SubjectFull: upper tract urothelial carcinoma
        Type: general
      – SubjectFull: UTUC
        Type: general
      – SubjectFull: sPD-L1
        Type: general
      – SubjectFull: soluble programmed death ligand-1
        Type: general
      – SubjectFull: biomarker
        Type: general
      – SubjectFull: prognosis
        Type: general
      – SubjectFull: immune checkpoint inhibitor therapy
        Type: general
      – SubjectFull: chemotherapy
        Type: general
      – SubjectFull: radical nephroureterectomy
        Type: general
      – SubjectFull: focal therapy
        Type: general
      – SubjectFull: kidney cancer
        Type: general
      – SubjectFull: thermal ablation
        Type: general
      – SubjectFull: renal carcinoma
        Type: general
      – SubjectFull: RCC
        Type: general
      – SubjectFull: PD-1
        Type: general
      – SubjectFull: PD-L1
        Type: general
      – SubjectFull: nivolumab
        Type: general
      – SubjectFull: kidney tumor
        Type: general
      – SubjectFull: systemic inflammatory response syndrome
        Type: general
      – SubjectFull: nephrectomy
        Type: general
      – SubjectFull: globotriaosylceramide
        Type: general
      – SubjectFull: rhamnose-binding lectin
        Type: general
      – SubjectFull: sunitinib
        Type: general
      – SubjectFull: brain metastases
        Type: general
      – SubjectFull: neurosurgery
        Type: general
      – SubjectFull: targeted therapy
        Type: general
      – SubjectFull: basement membrane
        Type: general
      – SubjectFull: diagnostic
        Type: general
      – SubjectFull: renal cancer
        Type: general
      – SubjectFull: lncRNA
        Type: general
      – SubjectFull: prognostic model
        Type: general
      – SubjectFull: immunotherapy
        Type: general
      – SubjectFull: prostate cancer
        Type: general
      – SubjectFull: transplant
        Type: general
      – SubjectFull: immunosuppression
        Type: general
      – SubjectFull: progression
        Type: general
      – SubjectFull: metastatic prostate cancer
        Type: general
      – SubjectFull: upper tract urothelial cancer
        Type: general
      – SubjectFull: Balkan endemic nephropathy
        Type: general
      – SubjectFull: morphology
        Type: general
      – SubjectFull: CKs
        Type: general
      – SubjectFull: CD44
        Type: general
      – SubjectFull: tyrosine kinase inhibitors (TKI)
        Type: general
      – SubjectFull: cabozantinib
        Type: general
      – SubjectFull: metastatic renal cell carcinoma (mRCC)
        Type: general
      – SubjectFull: adverse events
        Type: general
      – SubjectFull: predictive factor
        Type: general
      – SubjectFull: Applied mathematics
        Type: general
    Titles:
      – TitleFull: Advances in the Treatment of Kidney and Upper Urinary Tract Cancers
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zapała, Łukasz
      – PersonEntity:
          Name:
            NameFull: Rajwa, Pawel
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: isbn-print
              Value: 9783725805532
            – Type: isbn-print
              Value: 9783725805549
ResultId 1